Form 8-K - Current report:
SEC Accession No. 0001493152-24-023525
Filing Date
2024-06-12
Accepted
2024-06-12 06:01:19
Documents
23
Period of Report
2024-06-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41206
2 ex4-1.htm EX-4.1 12204
3 ex4-2.htm EX-4.2 13170
4 ex4-1_001.jpg GRAPHIC 11793
5 ex4-1_002.jpg GRAPHIC 13549
6 ex4-1_003.jpg GRAPHIC 5173
7 ex4-1_004.jpg GRAPHIC 7515
8 ex4-2_004.jpg GRAPHIC 12719
9 ex4-2_001.jpg GRAPHIC 8124
10 ex4-2_002.jpg GRAPHIC 5895
11 ex4-2_003.jpg GRAPHIC 5552
  Complete submission text file 0001493152-24-023525.txt   336557

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE ppcb-20240603.xsd EX-101.SCH 3012
13 XBRL LABEL FILE ppcb-20240603_lab.xml EX-101.LAB 34240
14 XBRL PRESENTATION FILE ppcb-20240603_pre.xml EX-101.PRE 22357
26 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3334
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54878 | Film No.: 241037432
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)